Shorted
Bioxyne logo
BXN
Household & Personal Products

Bioxyne

Short interest
0.02%
−0.02 pp 30d
as of 6 July 2026
Reported shorts
50K
Shares on issue
229.978M

Bioxyne (BXN) company profile

Profile, insiders and operations

Company

AI-generated research profile of Bioxyne

biotechnology
healthcare
pharmaceuticals
novel medicines
life sciences

Bioxyne is an international healthcare, life sciences, and novel medicines development company with operations in Australia, the United Kingdom, Japan, Czechia, Germany, and the United States. They focus on investigational & psychotropic medicines, healthcare technology, and novel consumer health products, aiming to revolutionize healthcare approaches.

Director trades

12 trades recorded

DateDirectorTypeSharesPriceValue
2026-05-15Unknown Director
buy
---
2026-05-12Anthony Ho
exercise options
5,000,000$0.020$100,000
2026-03-23Unknown Director
buy
---
2026-03-19Samuel Watson
buy
1,800,000$0.050$90,000
2025-12-24Samuel Watson
exercise options
79,000,000--
2025-12-24Unknown Director
buy
---
2025-10-27Jason Hine
buy
18,000,000--
2025-10-27Unknown Director
buy
---
2025-07-10Unknown Director
buy
---
2025-07-09Anthony Ho
sell
1,500,000$0.029$43,500
2024-12-19Anthony Ho
exercise options
15,000,000$0.006$89,000
2024-12-19Unknown Director
buy
---

BXN intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required